{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:26:00Z","timestamp":1791923160242,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR 20217 Hippocure"],"award-info":[{"award-number":["ANR 20217 Hippocure"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR 20217 Hippocure"],"award-info":[{"award-number":["ANR 20217 Hippocure"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s11010-024-04949-7","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T01:02:31Z","timestamp":1709254951000},"page":"231-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["YAP\/TEAD involvement in resistance to paclitaxel chemotherapy in lung cancer"],"prefix":"10.1007","volume":"480","author":[{"given":"S.","family":"Brosseau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bouchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Charon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Kieffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gentric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Picant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Veith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Camonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Descroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Mechta-Grigoriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Parrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zalcman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"4949_CR1","unstructured":"Global Cancer Observatory [Internet]. [cit\u00e9 5 oct 2022]. Disponible sur: https:\/\/gco.iarc.fr\/"},{"issue":"5","key":"4949_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.trecan.2019.02.010","volume":"5","author":"CDK Nguyen","year":"2019","unstructured":"Nguyen CDK, Yi C (2019) YAP\/TAZ signaling and resistance to cancer therapy. Trends Cancer 5(5):283\u2013296","journal-title":"Trends Cancer"},{"issue":"19","key":"4949_CR3","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1158\/0008-5472.CAN-14-0067","volume":"74","author":"L Volk-Draper","year":"2014","unstructured":"Volk-Draper L, Hall K, Griggs C, Rajput S, Kohio P, DeNardo D et al (2014) Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner. Cancer Res 74(19):5421\u20135434","journal-title":"Cancer Res"},{"issue":"5","key":"4949_CR4","first-page":"398","volume":"28","author":"ZX Han","year":"2013","unstructured":"Han ZX, Wang HM, Jiang G, Du XP, Gao XY, Pei DS (2013) Overcoming paclitaxel resistance in lung cancer cells via dual inhibition of stathmin and Bcl-2. Cancer Biother Radiopharm 28(5):398\u2013405","journal-title":"Cancer Biother Radiopharm"},{"issue":"47","key":"4949_CR5","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1038\/sj.onc.1206934","volume":"22","author":"GA Orr","year":"2003","unstructured":"Orr GA, Verdier-Pinard P, McDaid H, Horwitz SB (2003) Mechanisms of Taxol resistance related to microtubules. Oncogene 22(47):7280\u20137295","journal-title":"Oncogene"},{"issue":"6","key":"4949_CR6","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1200\/JCO.1999.17.6.1786","volume":"17","author":"M Monz\u00f3","year":"1999","unstructured":"Monz\u00f3 M, Rosell R, S\u00e1nchez JJ, Lee JS, O\u2019Brate A, Gonz\u00e1lez-Larriba JL et al (1999) Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations. J Clin Oncol 17(6):1786\u20131793","journal-title":"J Clin Oncol"},{"issue":"9","key":"4949_CR7","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1101\/gad.1909210","volume":"24","author":"B Zhao","year":"2010","unstructured":"Zhao B, Li L, Lei Q, Guan KL (2010) The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 24(9):862\u2013874","journal-title":"Genes Dev"},{"issue":"7","key":"4949_CR8","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.semcdb.2012.07.002","volume":"23","author":"J Avruch","year":"2012","unstructured":"Avruch J, Zhou D, Fitamant J, Bardeesy N, Mou F, Barrufet LR (2012) Protein kinases of the Hippo pathway: regulation and substrates. Semin Cell Dev Biol 23(7):770\u2013784","journal-title":"Semin Cell Dev Biol"},{"issue":"11","key":"4949_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.15698\/cst2021.11.258","volume":"5","author":"G Battilana","year":"2021","unstructured":"Battilana G, Zanconato F, Piccolo S (2021) Mechanisms of YAP\/TAZ transcriptional control. Cell Stress 5(11):167\u2013172","journal-title":"Cell Stress"},{"issue":"5","key":"4949_CR10","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1349-7006.2010.01511.x","volume":"101","author":"Y Wang","year":"2010","unstructured":"Wang Y, Dong Q, Zhang Q, Li Z, Wang E, Qiu X (2010) Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci 101(5):1279\u20131285","journal-title":"Cancer Sci"},{"issue":"10","key":"4949_CR11","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1158\/1078-0432.CCR-11-2797","volume":"18","author":"F de Fraipont","year":"2012","unstructured":"de Fraipont F, Levallet G, Creveuil C, Bergot E, Beau-Faller M, Mounawar M et al (2012) An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial. Clin Cancer Res 18(10):2976\u20132986","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4949_CR12","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato F, Cordenonsi M, Piccolo S (2016) YAP\/TAZ at the roots of cancer. Cancer Cell 29(6):783\u2013803","journal-title":"Cancer Cell"},{"issue":"13","key":"4949_CR13","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2217\/fon-2019-0035","volume":"15","author":"Z Tang","year":"2019","unstructured":"Tang Z, Ma Q, Wang L, Liu C, Gao H, Yang Z et al (2019) A brief review: some compounds targeting YAP against malignancies. Future Oncol 15(13):1535\u20131543","journal-title":"Future Oncol"},{"issue":"22","key":"4949_CR14","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1158\/1078-0432.CCR-15-0411","volume":"21","author":"A Sebio","year":"2015","unstructured":"Sebio A, Lenz HJ (2015) Molecular pathways: hippo signaling, a critical tumor suppressor. Clin Cancer Res 21(22):5002\u20135007","journal-title":"Clin Cancer Res"},{"key":"4949_CR15","doi-asserted-by":"crossref","unstructured":"Fromond C, Espanel X, Soud\u00e9 A, Chene L, Masson, P Boubia B, Montalbetti C, Broqua P. A rational approach for the discovery of inhibitors of the YAP-TEAD interaction\u201d Proceedings of the 106th AACR Annual meeting, April 18\u201322, Philadelphia, Cancer Res. 2015, 75 (15 suppl.) Abst. #220","DOI":"10.1158\/1538-7445.AM2015-2200"},{"key":"4949_CR16","doi-asserted-by":"crossref","unstructured":"Soud\u00e9 A, Barth M, Luccarini JM, Delaporte S, Chirade F, Valaire C, et al. Discovery of YAP-TEAD Protein-Protein Interaction inhibitors (PPI) for treating Malignant Pleural Mesothelioma (MPM)\u201d\u00a0ACR Special Conference on The Hippo Pathway: Signaling, Cancer, and Beyond, May 8\u201311 San Diego 2020. Mol Cancer Res. 2020, 18 (8 _Suppl.) Abst.nr B14","DOI":"10.1158\/1557-3125.HIPPO19-B14"},{"issue":"6","key":"4949_CR17","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1158\/0008-5472.CAN-15-1008","volume":"76","author":"F Dubois","year":"2016","unstructured":"Dubois F, Keller M, Calvayrac O, Soncin F, Hoa L, Hergovich A et al (2016) RASSF1A suppresses the invasion and metastatic potential of human non-small cell lung cancer cells by inhibiting YAP activation through the GEF-H1\/RhoB pathway. Cancer Res 76(6):1627\u20131640","journal-title":"Cancer Res"},{"issue":"1","key":"4949_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13046-019-1145-8","volume":"38","author":"M Keller","year":"2019","unstructured":"Keller M, Dubois F, Teulier S, Martin APJ, Levallet J, Maille E et al (2019) NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells. J Exp Clin Cancer Res 38(1):158","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"4949_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41568-018-0104-6","volume":"19","author":"A Sontheimer-Phelps","year":"2019","unstructured":"Sontheimer-Phelps A, Hassell BA, Ingber DE (2019) Modelling cancer in microfluidic human organs-on-chips. Nat Rev Cancer 19(2):65\u201381","journal-title":"Nat Rev Cancer"},{"issue":"13","key":"4949_CR20","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1016\/j.celrep.2018.12.015","volume":"25","author":"M Nguyen","year":"2018","unstructured":"Nguyen M, De Ninno A, Mencattini A, Mermet-Meillon F, Fornabaio G, Evans SS et al (2018) Dissecting effects of anti-cancer drugs and cancer-associated fibroblasts by on-chip reconstitution of immunocompetent tumor microenvironments. Cell Rep 25(13):3884-3893.e3","journal-title":"Cell Rep"},{"issue":"21","key":"4949_CR21","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1039\/C6LC00718J","volume":"16","author":"R Portillo-Lara","year":"2016","unstructured":"Portillo-Lara R, Annabi N (2016) Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment. Lab Chip 16(21):4063\u20134081","journal-title":"Lab Chip"},{"issue":"4","key":"4949_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41416-019-0379-8","volume":"120","author":"E Maille","year":"2019","unstructured":"Maille E, Brosseau S, Hanoux V, Creveuil C, Danel C, Bergot E et al (2019) MST1\/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial. Br J Cancer 120(4):387\u2013397","journal-title":"Br J Cancer"},{"issue":"11","key":"4949_CR23","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nmeth.2209","volume":"9","author":"M Deforet","year":"2012","unstructured":"Deforet M, Parrini MC, Petitjean L, Biondini M, Buguin A, Camonis J et al (2012) Automated velocity mapping of migrating cell populations (AVeMap). Nat Methods 9(11):1081\u20131083","journal-title":"Nat Methods"},{"issue":"3","key":"4949_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008870","volume":"17","author":"I Veith","year":"2021","unstructured":"Veith I, Mencattini A, Picant V, Serra M, Leclerc M, Comes MC et al (2021) Apoptosis mapping in space and time of 3D tumor ecosystems reveals transmissibility of cytotoxic cancer death. PLoS Comput Biol 17(3):e1008870","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"4949_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004527","volume":"10","author":"S Corgnac","year":"2022","unstructured":"Corgnac S, Damei I, Gros G, Caidi A, Terry S, Chouaib S et al (2022) Cancer stem-like cells evade CD8+CD103+ tumor-resident memory T (TRM) lymphocytes by initiating an epithelial-to-mesenchymal transition program in a human lung tumor model. J Immunother Cancer 10(4):e004527","journal-title":"J Immunother Cancer"},{"key":"4949_CR26","doi-asserted-by":"publisher","first-page":"11759","DOI":"10.1038\/srep11759","volume":"5","author":"M Biondini","year":"2015","unstructured":"Biondini M, Duclos G, Meyer-Schaller N, Silberzan P, Camonis J, Parrini MC (2015) RalB regulates contractility-driven cancer dissemination upon TGF\u03b2 stimulation via the RhoGEF GEF-H1. Sci Rep 5:11759","journal-title":"Sci Rep"},{"issue":"3","key":"4949_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ng.3218","volume":"47","author":"L Lin","year":"2015","unstructured":"Lin L, Sabnis AJ, Chan E, Olivas V, Cade L, Pazarentzos E et al (2015) The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies. Nat Genet 47(3):250\u2013256","journal-title":"Nat Genet"},{"issue":"7350","key":"4949_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M et al (2011) Role of YAP\/TAZ in mechanotransduction. Nature 474(7350):179\u2013183","journal-title":"Nature"},{"issue":"8","key":"4949_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005465","volume":"11","author":"C Stein","year":"2015","unstructured":"Stein C, Bardet AF, Roma G, Bergling S, Clay I, Ruchti A et al (2015) YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers. PLoS Genet 11(8):e1005465","journal-title":"PLoS Genet"},{"issue":"9","key":"4949_CR30","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/ncb3216","volume":"17","author":"F Zanconato","year":"2015","unstructured":"Zanconato F, Forcato M, Battilana G, Azzolin L, Quaranta E, Bodega B et al (2015) Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol 17(9):1218\u20131227","journal-title":"Nat Cell Biol"},{"issue":"4","key":"4949_CR31","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/sj.emboj.7600073","volume":"23","author":"SK Zaidi","year":"2004","unstructured":"Zaidi SK, Sullivan AJ, Medina R, Ito Y, van Wijnen AJ, Stein JL, Lian JB, Stein GZ (2004) Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J 23(4):790\u2013799","journal-title":"EMBO J"},{"issue":"26","key":"4949_CR32","doi-asserted-by":"publisher","first-page":"E630","DOI":"10.1073\/pnas.1717782115","volume":"115","author":"PD Fan","year":"2018","unstructured":"Fan PD, Narzisi G, Jayaprakash AD, Venturini E, Robine N, Smibert P et al (2018) YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics. Proc Natl Acad Sci 115(26):E630\u2013E638","journal-title":"Proc Natl Acad Sci"},{"issue":"32","key":"4949_CR33","doi-asserted-by":"publisher","first-page":"51922","DOI":"10.18632\/oncotarget.10458","volume":"7","author":"PC Hsu","year":"2016","unstructured":"Hsu PC, You B, Yang YL, Zhang WQ, Wang YC, Xu Z et al (2016) YAP promotes erlotinib resistance in human non-small cell lung cancer cells. Oncotarget 7(32):51922\u201351933","journal-title":"Oncotarget"},{"issue":"1","key":"4949_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41467-022-28319-3","volume":"13","author":"D Esposito","year":"2022","unstructured":"Esposito D, Pant I, Shen Y, Qiao RF, Yang X, Bai Y et al (2022) ROCK1 mechano-signaling dependency of human malignancies driven by TEAD\/YAP activation. Nat Commun 13(1):703","journal-title":"Nat Commun"},{"issue":"3","key":"4949_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.critrevonc.2009.11.006","volume":"75","author":"DJ Stewart","year":"2010","unstructured":"Stewart DJ (2010) Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Crit Rev Oncol Hematol Sept 75(3):173\u2013234","journal-title":"Crit Rev Oncol Hematol Sept"},{"key":"4949_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt356","author":"DJ Stewart","year":"2013","unstructured":"Stewart DJ (2013) Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djt356","journal-title":"J Natl Cancer Inst"},{"issue":"40","key":"4949_CR37","doi-asserted-by":"publisher","first-page":"eabd1850","DOI":"10.1126\/sciadv.abg1850","volume":"7","author":"Q Wu","year":"2021","unstructured":"Wu Q, Guo J, Liu Y, Zheng Q, Li X, Wu C et al (2021) YAP drives fate conversion and chemoresistance of small cell lung cancer. Sci Adv 7(40):eabd1850","journal-title":"Sci Adv"},{"issue":"9","key":"4949_CR38","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/CAD.0b013e3283475f70","volume":"22","author":"D Decaudin","year":"2011","unstructured":"Decaudin D (2011) Primary human tumor xenografted models (\u2018tumorgrafts\u2019) for good management of patients with cancer. Anticancer Drugs 22(9):827\u2013841","journal-title":"Anticancer Drugs"},{"issue":"5986","key":"4949_CR39","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.1188302","volume":"328","author":"D Huh","year":"2010","unstructured":"Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE (2010) Reconstituting organ-level lung functions on a chip. Science 328(5986):1662\u20131668","journal-title":"Science"},{"issue":"2","key":"4949_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nmeth.3697","volume":"13","author":"KH Benam","year":"2016","unstructured":"Benam KH, Villenave R, Lucchesi C, Varone A, Hubeau C, Lee HH et al (2016) Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro. Nat Methods 13(2):151\u2013157","journal-title":"Nat Methods"},{"issue":"2","key":"4949_CR41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/cpt.742","volume":"103","author":"A Jain","year":"2018","unstructured":"Jain A, Barrile R, van der Meer AD, Mammoto A, Mammoto T, De Ceunynck K et al (2018) Primary human lung alveolus-on-a-chip model of intravascular thrombosis for assessment of therapeutics. Clin Pharmacol Ther 103(2):332\u2013340","journal-title":"Clin Pharmacol Ther"},{"key":"4949_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2022.114571","volume":"215","author":"A Mencattini","year":"2022","unstructured":"Mencattini A, Lansche C, Veith I, Erbs P, Balloul JM, Quemeneur E et al (2022) Direct imaging and automatic analysis in tumor-on-chip reveal cooperative antitumoral activity of immune cells and oncolytic vaccinia virus. Biosens Bioelectron 215:114571","journal-title":"Biosens Bioelectron"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-04949-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-024-04949-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-04949-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T15:03:53Z","timestamp":1735830233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-024-04949-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4949"],"URL":"https:\/\/doi.org\/10.1007\/s11010-024-04949-7","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"assertion":[{"value":"15 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}